WHITNEY ADELMAN: Open Payments
NPI 1710420898 · REDDING, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,082 in 127 payments from 14 companies in 2025. Trend: 2023 $1,827 · 2024 $2,033 · 2025 $2,082
Food & beverage: $2,039Education: $43
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $481 |
| GENZYME CORPORATION | 11 | $339 |
| Lilly USA, LLC | 19 | $227 |
| Galderma Laboratories, L.P. | 12 | $206 |
| UCB, Inc. | 13 | $186 |
| Janssen Biotech, Inc. | 10 | $135 |
| LEO Pharma Inc. | 6 | $122 |
| Regeneron Healthcare Solutions, Inc. | 5 | $107 |
| Incyte Corporation | 4 | $103 |
| Novartis Pharmaceuticals Corporation | 4 | $75 |
Products named: DUPIXENT, RINVOQ, TALTZ, Bimzelx, NEMLUVIO, SKYRIZI, TREMFYA, AYVAKIT.
Industry payments across CA — which companies pay providers there.
